NIFTY 50

Kiran Mazumdar-Shaw says Biocon Biologics may launch an IPO in next 18-24 months

Updated : January 24, 2020 03:23 PM IST

The company, which reported its Q3 numbers on Thursday, has just received a $75 million injection into Biocon Biologics from a private equity funding, said Kiran Mazumdar Shaw.
The Bengaluru-based company's revenue was in-line, up 13.5 percent, in Q3.
Biocon's margins took a hit because of higher R&D and remediation expenses on the Malaysia facility.

You May Also Like

Live TV